PT87616A - Process for the preparation of leukotriene antagonists and of pharmaceutical compounds - Google Patents

Process for the preparation of leukotriene antagonists and of pharmaceutical compounds

Info

Publication number
PT87616A
PT87616A PT87616A PT8761688A PT87616A PT 87616 A PT87616 A PT 87616A PT 87616 A PT87616 A PT 87616A PT 8761688 A PT8761688 A PT 8761688A PT 87616 A PT87616 A PT 87616A
Authority
PT
Portugal
Prior art keywords
alkyl
preparation
leukotriene antagonists
alkoxy
pharmaceutical compounds
Prior art date
Application number
PT87616A
Other languages
English (en)
Other versions
PT87616B (pt
Inventor
John Gerald Gleason
Ralph Floyd Hall
Irene Nijole Uzinskas
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of PT87616A publication Critical patent/PT87616A/pt
Publication of PT87616B publication Critical patent/PT87616B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT87616A 1987-06-24 1988-05-30 Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas PT87616B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6659287A 1987-06-24 1987-06-24

Publications (2)

Publication Number Publication Date
PT87616A true PT87616A (pt) 1988-06-01
PT87616B PT87616B (pt) 1992-09-30

Family

ID=22070480

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87616A PT87616B (pt) 1987-06-24 1988-05-30 Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas

Country Status (11)

Country Link
US (1) US5135938A (pt)
EP (1) EP0296731B1 (pt)
JP (1) JP2677382B2 (pt)
AT (1) ATE79873T1 (pt)
AU (1) AU1759488A (pt)
DE (1) DE3874021T2 (pt)
DK (1) DK327188A (pt)
ES (1) ES2051850T3 (pt)
GR (1) GR3006224T3 (pt)
PT (1) PT87616B (pt)
ZA (1) ZA884239B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254571A (en) * 1988-04-21 1993-10-19 Smith Kline & French Laboratories Ltd. Chemical compounds
EP0532674A4 (en) * 1990-06-06 1993-04-07 Smithkline Beecham Corporation Leukotriene antagonists
WO2018234267A1 (de) * 2017-06-19 2018-12-27 Sika Technology Ag Latenter härter und härtbare polyurethanzusammensetzung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins
US4286089A (en) 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
US3989694A (en) 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins
US4048311A (en) 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4220644A (en) 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
IL69691A (en) * 1982-09-23 1988-01-31 Merck Frosst Canada Inc Leukotriene antagonists,their preparation and pharmaceutical compositions containing them
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
JPS59161366A (ja) * 1983-03-04 1984-09-12 Zenichi Yoshida チアジアゾリノン類
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
GR81524B (pt) * 1983-07-18 1984-12-11 Lilly Co Eli
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
GB8432144D0 (en) * 1984-12-20 1985-01-30 Lilly Industries Ltd Organic compounds
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
ATE72431T1 (de) * 1985-08-31 1992-02-15 Fisons Plc 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren.
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
ES2051850T3 (es) 1994-07-01
EP0296731B1 (en) 1992-08-26
AU1759488A (en) 1989-01-05
DE3874021T2 (de) 1993-02-11
EP0296731A1 (en) 1988-12-28
US5135938A (en) 1992-08-04
JPS6426571A (en) 1989-01-27
JP2677382B2 (ja) 1997-11-17
DK327188D0 (da) 1988-06-15
ZA884239B (en) 1989-06-28
PT87616B (pt) 1992-09-30
DK327188A (da) 1988-12-25
ATE79873T1 (de) 1992-09-15
GR3006224T3 (pt) 1993-06-21
DE3874021D1 (de) 1992-10-01

Similar Documents

Publication Publication Date Title
HUP9802578A2 (hu) Fenil-ecetsav-származékok, eljárás és intermedierek előállításukhoz, a vegyületeket hatóanyagként tartalmazó fungicid, inszekticid, arachnicid és nematocid készítmények és alkalmazásuk
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
ES480850A1 (es) Procedimiento para preparar hidantoinas.
DK633088D0 (da) Hidtil ukendte forbindelser
ID26179A (id) Turunan-turunan benzenasulfonamida dan penggunaannya sebagai obat-obatan
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
SE0201937D0 (sv) Therapeutic agents
DE3777544D1 (de) Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen.
PT87615A (pt) Process for the preparation of leukotriene antagonists and of pharmaceutical compounds
ATE79873T1 (de) Leukotrien-antagonisten.
DK37580A (da) 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater samt deres fremstilling og anvendelse
DE3688161D1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
HUP9802571A2 (hu) Piridin-iminil-1,2-benzizoxazolok és -benzizotiazolok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
MX21139A (es) Antagonistas del leucotrieno.
JPS5325533A (en) Novel phenylacetic acid derivatives
DK0401125T3 (da) Biphenylderivater, fremgangsmåde til fremstilling af disse samt mellemprodukter derfor
JPS5412348A (en) Cyclopropane carboxylic acid esters, their preparation, and insecticides and acaricides comprising them as active constituents
YU134591A (sh) Postupak i intermedijer za dobijanje 2-hidroksi-3-sulfido-3- fenilpropionske kiseline
DE69014239D1 (de) Phenylglycidamide, verwendbar in der Herstellung von alpha-Hydroxy-beta-sulfido-arylpropionsäure-Derivaten.
JPS53127444A (en) Oxime substd. phenylacetic acid derivtives and their preparation
ES2149958T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
HRP20000279B1 (en) Process for the preparation of sildenaphyl and intermediates
EP0035285A3 (en) Novel isoxazole carboxylic acid phenyl esters, pharmaceutical compositions containing certain of said esters, and process for preparing said esters
JPS5492955A (en) Heterocyclic compound and its preparation

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920312

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950930